International archives of allergy and immunology · 2009
Regulation of peroxisome proliferator-activated receptor-gamma expression in human eosinophils by estradiol.
Сравнительное исследованиеСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ueki Shigeharu, Oguma Mariko, Usami Atsuko, Kamada Yumiko, Kato Hikari, Kamada Rie, Takeda Masahide, Ito Wataru, Tanigai Tomomi, Kayaba Hiroyuki, Chihara Junichi
Аннотация
BACKGROUND: Peroxisome proliferator-activated receptor-gamma (PPARgamma) is a nuclear receptor that regulates not only adipogenesis but also immune reaction. We previously demonstrated that human eosinophils expressed functional PPARgamma, although the modulator of PPARgamma expression is less well understood. Because clinical studies have shown that the efficacy of PPARgamma agonists as insulin sensitizers is stronger in women than in men, we investigated whether sex hormones caused any changes in eosinophil PPARgamma expression levels.
METHODS: First, purified human peripheral blood eosinophils were cultured with 17beta-estradiol for 24 h, followed by PPARgamma measurement using a flow cytometer. Next, eosinophil PPARgamma expression and serum estradiol were studied in 10 healthy women during the menstrual and follicular phases to identify the physiological significance of estradiol. Eosinophil PPARgamma expression was also compared in 22 men, 21 non-pregnant women, and 15 pregnant women.
RESULTS: We observed that PPARgamma protein expression in eosinophils was significantly enhanced by 10(-6)M 17beta-estradiol. Although serum estradiol concentration was increased during the follicular phase, PPARgamma expression levels were not affected by the menstrual cycle. In addition, no significant differences in PPARgamma expression were observed in terms of sex and pregnancy.
CONCLUSIONS: These findings suggest that estradiol potentially upregulates eosinophil PPARgamma expression in vitro, although some other mechanisms might be involved in its regulation in vivo.
METHODS: First, purified human peripheral blood eosinophils were cultured with 17beta-estradiol for 24 h, followed by PPARgamma measurement using a flow cytometer. Next, eosinophil PPARgamma expression and serum estradiol were studied in 10 healthy women during the menstrual and follicular phases to identify the physiological significance of estradiol. Eosinophil PPARgamma expression was also compared in 22 men, 21 non-pregnant women, and 15 pregnant women.
RESULTS: We observed that PPARgamma protein expression in eosinophils was significantly enhanced by 10(-6)M 17beta-estradiol. Although serum estradiol concentration was increased during the follicular phase, PPARgamma expression levels were not affected by the menstrual cycle. In addition, no significant differences in PPARgamma expression were observed in terms of sex and pregnancy.
CONCLUSIONS: These findings suggest that estradiol potentially upregulates eosinophil PPARgamma expression in vitro, although some other mechanisms might be involved in its regulation in vivo.